Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

Ramsay Santé seals GHP acquisition with 96.6% of shares

Ramsay Santé, the European branch of multinational hospital giant Ramsay Healthcare, has sealed the deal for its acquisition of listed Swedish specialty care provider GHP Specialty Care, having obtained 96.6% of its shares before the closing of the initial acceptance period on Friday, April 22.

Elsan’s digital approach to primary care  

Paris-based hospital group Elsan says it will open two “highly digitised” primary care facilities by the end of the year in cooperation with Livi, the developer of the e-health platform owned by the Swedish startup Kry. HBI speaks with Thierry Chiche, CEO at Elsan and Jonathan Ardouin, Managing Director at Livi France, to learn more. 

Sanoptis sells to unexpected buyer

As predicted by HBI earlier this year, fast-growing German and Swiss ophthalmology group Sanoptis has sold - but to an unexpected buyer. Owner Telemos Capital has signed an agreement to sell to family-backed investment holding company Groupe Bruxelles Lambert (GBL), the same group which has also just agreed to buy a majority stake in European imaging and cancer treatment provider Affidea.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Artemis founder speaks out after damning documentary on primetime TV

A primetime ‘exposé’ of how private equity operates in the German ophthalmology market had some of its largest operators in its crosshairs last week. We talk to the founder of Artemis Augenkliniken, who was interviewed on camera, and a specialist healthcare lawyer, for their take on hitting the headlines for the wrong reasons.

Karl Lauterbach u-turns on voluntary quarantine and loses mandatory vaccine vote

Last week was a rough one for German health minister Karl Lauterbach. First he made an embarrassing u-turn on his decision to end mandatory Covid quarantines and then his government's proposal to introduce mandatory vaccinations, which he has been championing since entering office, was rejected by legislators.

Mediclinic returns to growth in FY22

A strong performance at home saw South African hospital group Mediclinic's revenue grow 8% in the financial year ending March 31, 2022 and its EBITDA margin move up two percentage points to 16%.

Attend Anywhere (mostly) retains grip on NHS outpatient telehealth

UK telehealth provider Attend Anywhere saw 94% of its one-year NHS contracts that were up for tender renewed this month, with the majority of the renewed contracts being for two or three years. This means it will remain the major provider of telehealth services to NHS outpatient departments for at least the next two years.

Ardian “looking to sell Inovie stake”

Last week we reported that French lab group Inovie is currently in the process of looking for a new majority shareholder. Could private equity fund Ardian be looking to sell its (minority) stake.

Find Us